These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 22842290)

  • 1. Mass spectrometry imaging for drug distribution studies.
    Prideaux B; Stoeckli M
    J Proteomics; 2012 Aug; 75(16):4999-5013. PubMed ID: 22842290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging and spatially resolved quantification of drug distribution in tissues by mass spectrometry.
    Prideaux B; Lenaerts A; Dartois V
    Curr Opin Chem Biol; 2018 Jun; 44():93-100. PubMed ID: 29957376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exemplifying the Screening Power of Mass Spectrometry Imaging over Label-Based Technologies for Simultaneous Monitoring of Drug and Metabolite Distributions in Tissue Sections.
    Goodwin RJ; Nilsson A; Mackay CL; Swales JG; Johansson MK; Billger M; Andrén PE; Iverson SL
    J Biomol Screen; 2016 Feb; 21(2):187-93. PubMed ID: 26701101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug localizations in tissue by mass spectrometry imaging.
    Végvári Á
    Biomark Med; 2015; 9(9):869-76. PubMed ID: 26328625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging mass spectrometry for the assessment of drugs and metabolites in tissue.
    Trim PJ; Francese S; Clench MR
    Bioanalysis; 2009 May; 1(2):309-19. PubMed ID: 21083170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of imaging mass spectrometry (IMS) by matrix-assisted laser desorption ionization (MALDI) on an ion trap mass spectrometer in the analysis of drugs and metabolites in biological tissues.
    Drexler DM; Garrett TJ; Cantone JL; Diters RW; Mitroka JG; Prieto Conaway MC; Adams SP; Yost RA; Sanders M
    J Pharmacol Toxicol Methods; 2007; 55(3):279-88. PubMed ID: 17222568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualitative and quantitative mass spectrometry imaging of drugs and metabolites.
    Lietz CB; Gemperline E; Li L
    Adv Drug Deliv Rev; 2013 Jul; 65(8):1074-85. PubMed ID: 23603211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MALDI imaging mass spectrometry: bridging biology and chemistry in drug development.
    Castellino S; Groseclose MR; Wagner D
    Bioanalysis; 2011 Nov; 3(21):2427-41. PubMed ID: 22074284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of Mass Spectrometry Imaging for Safety Evaluation.
    Bonnel D; Stauber J
    Methods Mol Biol; 2017; 1641():129-140. PubMed ID: 28748461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometry imaging of cassette-dosed drugs for higher throughput pharmacokinetic and biodistribution analysis.
    Swales JG; Tucker JW; Strittmatter N; Nilsson A; Cobice D; Clench MR; Mackay CL; Andren PE; Takáts Z; Webborn PJ; Goodwin RJ
    Anal Chem; 2014 Aug; 86(16):8473-80. PubMed ID: 25084360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping drug distribution in brain tissue using liquid extraction surface analysis mass spectrometry imaging.
    Swales JG; Tucker JW; Spreadborough MJ; Iverson SL; Clench MR; Webborn PJ; Goodwin RJ
    Anal Chem; 2015 Oct; 87(19):10146-52. PubMed ID: 26350423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ metabolomic mass spectrometry imaging: recent advances and difficulties.
    Miura D; Fujimura Y; Wariishi H
    J Proteomics; 2012 Aug; 75(16):5052-5060. PubMed ID: 22366554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass Spectrometry Imaging: Applications in Drug Distribution Studies.
    Zhao YS; Li C
    Curr Drug Metab; 2015; 16(9):807-15. PubMed ID: 26264197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging of drug and metabolite distribution by MS: case studies.
    Takai N; Tanaka Y
    Bioanalysis; 2015; 7(20):2639-48. PubMed ID: 26505832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From molecules to visuals: Empowering drug discovery and development with mass spectrometry imaging.
    Chen B; Vavrek M; Cancilla MT
    J Mass Spectrom; 2024 May; 59(5):e5029. PubMed ID: 38656528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative profiling of tissue drug distribution by MS imaging.
    Pirman D
    Bioanalysis; 2015; 7(20):2649-56. PubMed ID: 26495807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass spectrometry imaging of therapeutics from animal models to three-dimensional cell cultures.
    Liu X; Hummon AB
    Anal Chem; 2015 Oct; 87(19):9508-19. PubMed ID: 26084404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue distribution and metabolic profiling of cyclosporine (CsA) in mouse and rat investigated by DESI and MALDI mass spectrometry imaging (MSI) of whole-body and single organ cryo-sections.
    Holm NB; Deryabina M; Knudsen CB; Janfelt C
    Anal Bioanal Chem; 2022 Oct; 414(24):7167-7177. PubMed ID: 35953725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of quantitative whole-body autoradiography (QWBA) and imaging mass spectrometry (IMS) by matrix-assisted laser desorption/ionization (MALDI) in the assessment of ocular distribution of drugs.
    Drexler DM; Tannehill-Gregg SH; Wang L; Brock BJ
    J Pharmacol Toxicol Methods; 2011; 63(2):205-8. PubMed ID: 21040797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometry imaging is moving toward drug protein co-localization.
    Ait-Belkacem R; Sellami L; Villard C; DePauw E; Calligaris D; Lafitte D
    Trends Biotechnol; 2012 Sep; 30(9):466-74. PubMed ID: 22762968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.